New Zymeworks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New zymeworks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Zymeworks Today - Breaking & Trending Today

Zymeworks Inc. (ZYME): How investors can get the most out of their investments

Zymeworks Inc. (ZYME) is priced at $5.52 after the most recent trading session. At the very opening of the session, the stock price was $4.88 and reached a high price of $5.65, prior to closing the session it reached the value of $4.89. The stock touched a low price of $4.88.Recently in News on Octo ....

United States , Zymeworks Completes Plan To Become Delaware Corporation , Zymeworks Delaware Inc , Zymeworks Inc , Zymeworks Exchangeco Ltd , Zymeworks Inc New , Zymeworks Bc Inc Legacy , Zymeworks Completes Plan , Become Delaware , Zymeworks Delaware , New Zymeworks , British Columbia , Legacy Zymeworks , Zymeworks Exchangeco , Special Meeting , Own Right , Equity Ratio , Raw Stochastic , Nyse Zyme , Yme Shares , Yme Stock , Ymeworks Inc , Ymeworks Inc Nyse Zyme ,

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United States , British Columbia , Kenneth Galbraith , Exchange Commission , Zymeworks Inc , Zymeworks Delaware Inc , Securities Exchange , Special Meeting , Votes For , Votes Against , Votes Abstain , Current Report , New Zymework , New Zymeworks , Canadian Securities Administrators , Zymework Amendment , Annual Report , Securities Act , Securities Exchange Act , Zymework Annual Report , Quarterly Report ,

Zymeworks Announces Results of Special Meeting

Zymeworks Inc. (“Zymeworks” or the “Company”) (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, is pleased to announce that the Company’s securityholders have approved its p. ....

United States , British Columbia , Kenneth Galbraith , Exchange Commission , Zymeworks Inc , Zymeworks Delaware Inc , Securities Exchange , Special Meeting , Votes For , Votes Against , Votes Abstain , Current Report , New Zymework , New Zymeworks , Canadian Securities Administrators , Zymework Amendment , Annual Report , Securities Act , Securities Exchange Act , Zymework Annual Report , Quarterly Report ,